What is it about?

This article emphasizes the importance of using advanced lab technologies and AI to analyze lifelong environmental exposures (the exposome) alongside genetics. This approach helps in early detection and prevention of heart disease, aiming for more personalized and effective healthcare.

Featured Image

Read the Original

This page is a summary of: Contribution of laboratory medicine and emerging technologies to cardiovascular risk reduction via exposome analysis: an opinion of the IFCC Division on Emerging Technologies, Clinical Chemistry and Laboratory Medicine (CCLM), September 2024, De Gruyter,
DOI: 10.1515/cclm-2024-0788.
You can read the full text:

Read

Contributors

Be the first to contribute to this page